Literature DB >> 19698809

Decision support in vaccination policies.

B Piso1, C Wild.   

Abstract

BACKGROUND: Looking across boarders reveals that the national immunization programs of various countries differ in their vaccination schedules and decisions regarding the implementation and funding of new vaccines. The aim of this review is to identify decision aids and crucial criteria for a rational decision-making process on vaccine introduction and to develop a theoretical framework for decision-making based on available literature.
METHODS: Systematic literature search supplemented by hand-search.
RESULTS: We identified five published decision aids for vaccine introduction and program planning in industrialized countries. Their comparison revealed an overall similarity with some differences in the approach as well as criteria. Burden of disease and vaccine characteristics play a key role in all decision aids, but authors vary in their views on the significance of cost-effectiveness analyses. Other relevant factors that should be considered before vaccine introduction are discussed to highly differing extents. These factors include the immunization program itself as well as its conformity with other programs, its feasibility, acceptability, and equity, as well as ethical, legal and political considerations. Assuming that the most comprehensive framework possible will not provide a feasible tool for decision-makers, we suggest a stepwise procedure.
CONCLUSIONS: Though even the best rational approach and most comprehensive evaluation is limited by remaining uncertainties, frameworks provide at least a structured approach to evaluate the various aspects of vaccine implementation decision-making. This process is essential in making consistently sound decisions and will facilitate the public's confidence in the decision and its realization.

Mesh:

Year:  2009        PMID: 19698809     DOI: 10.1016/j.vaccine.2009.07.105

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

1.  [Opinion on Schwarz E., Maier M. Publication output in the field of Public Health and its appreciation at political level in Austria, Wien Med Wochenschr (2014) 164:123-130].

Authors:  Brigitte Piso; Ingrid Zechmeister-Koss; Claudia Wild
Journal:  Wien Med Wochenschr       Date:  2014-12

Review 2.  Development of the WHO-INTEGRATE evidence-to-decision framework: an overview of systematic reviews of decision criteria for health decision-making.

Authors:  J M Stratil; R Baltussen; I Scheel; A Nacken; E A Rehfuess
Journal:  Cost Eff Resour Alloc       Date:  2020-02-11

3.  Results from evaluations of models and cost-effectiveness tools to support introduction decisions for new vaccines need critical appraisal.

Authors:  Raymond Hutubessy; Ana Maria Henao; Pem Namgyal; Vasee Moorthy; Joachim Hombach
Journal:  BMC Med       Date:  2011-05-12       Impact factor: 8.775

4.  Health and economic outcomes of introducing the new MenB vaccine (Bexsero) into the Italian routine infant immunisation programme.

Authors:  Marcello Tirani; Michela Meregaglia; Alessia Melegaro
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

5.  Stakeholders' perception on including broader economic impact of vaccines in economic evaluations in low and middle income countries: a mixed methods study.

Authors:  Ingeborg M van der Putten; Silvia M A A Evers; Rohan Deogaonkar; Mark Jit; Raymond C W Hutubessy
Journal:  BMC Public Health       Date:  2015-04-10       Impact factor: 3.295

6.  Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community.

Authors:  Bernhard Ultsch; Oliver Damm; Philippe Beutels; Joke Bilcke; Bernd Brüggenjürgen; Andreas Gerber-Grote; Wolfgang Greiner; Germaine Hanquet; Raymond Hutubessy; Mark Jit; Mirjam Knol; Rüdiger von Kries; Alexander Kuhlmann; Daniel Levy-Bruhl; Matthias Perleth; Maarten Postma; Heini Salo; Uwe Siebert; Jürgen Wasem; Ole Wichmann
Journal:  Pharmacoeconomics       Date:  2016-03       Impact factor: 4.981

7.  The Potential Cost-Effectiveness of HIV Vaccines: A Systematic Review.

Authors:  Blythe Adamson; Dobromir Dimitrov; Beth Devine; Ruanne Barnabas
Journal:  Pharmacoecon Open       Date:  2017-01-30

8.  WICID framework version 1.0: criteria and considerations to guide evidence-informed decision-making on non-pharmacological interventions targeting COVID-19.

Authors:  Jan M Stratil; Maike Voss; Laura Arnold
Journal:  BMJ Glob Health       Date:  2020-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.